Immunomodulators for treatment and prevention of respiratory and herpesvirus infections

Influenza and herpes viruses cause epidemics and pandemics in the population, target various organs and tissues, persist in the cells of nervous and immune systems and trigger the development of the secondary immunodeficiency. As a result, patients present with an imbalance in Tand B-cell immunity together with impaired cytokine production including endogenous interferons. Inosine pranobex (Groprinosin) exhibits established antiviral and immunomodulatory activity. Clinical studies showed efficacy and safety of inosine pranobex in the treatment and prevention of respiratory and herpesvirus infections both in children and adults.

Key words

Respiratory infections, herpes, inosine pranobex.